Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: Prospective study

Journal of Otolaryngology - Head and Neck Surgery

Volumn 40, Issue 4, 2011, Pages 350-356

  Ezzat, Waleed F ^a   Fawaz, Samya A ^a   Fathey, Hanaa ^a   El Demerdash, Ahmed ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b MILITARY MEDICAL ACADEMY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ITOPRIDE; PANTOPRAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYMPTOMATOLOGY;

ADULT; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; TREATMENT OUTCOME; VIRTUES;

EID: 80052209715     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2011.100196     Document Type: Article

References (20)

1. Koufinan JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24 hour monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1-78.
2. Lundell L, Myers JC, Jamieson GG. Is motility impaired in the entire upper gastrointestinal tract in patients with gastrooesophageal reflux disease? Scand J Gastroenterol 1996;31:131-5, doi:10.3109/00365529609031976. (Pubitemid 26048719)
3. Ahuja V, Yencha MW, Lassen LF. Head and neck manifestations of gastroesophageal reflux disease. Am Fam Physician 1999;60:873-80, 885-6.
4. Duval M, Black MA, Gesser R, et al. Multidisciplinary evaluation and management of dysphagia: the role for otolaryngologists. J Otolaryngol Head Neck Surg 2009;38:227-32.
5. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the Reflux Symptom Index (RSI). J Voice 2002;16:274-7, doi:10.1016/S0892-1997(02) 00097-8. (Pubitemid 36626833)
6. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534-40, doi:10.1001/jama.294.12.1534. (Pubitemid 41362691)
7. Qua CS, Wong CH, Gopala K, Goh KL. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy. Aliment Pharmacol Ther 2007;25:287-95, doi:10.1111/j.1365-2036.2006.03185.x. (Pubitemid 46115398)
8. Postma GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol Suppl 2000;184:10-4.
9. Nostrant TT. Gastroesophageal reflux and laryngitis: a skeptic's view. Am J Med 2000;108 Suppl 4a:149S-52S, doi:10.1016/S0002-9343(99)00355-1.
10. Baldi F. Diagnostic strategy in patients with extraesophageal GERD. Curr Gastroenterol Rep 2002;4:99-100, doi:10.1007/s11894-002-0043-x.
11. Noordzij JP, Khidr A, Desper E, et al. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002;112:2192-5, doi:10.1097/00005537-200212000-00013. (Pubitemid 35417042)
12. Kim KS, Kim TH, Choi CS, et al. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. World J Gastroenterol 2005;11:4210-4. (Pubitemid 41086873)
13. Carrau RL, Khidr A, Gold KF, et al. Validation of a quality-of-life instrument for laryngopharyngeal reflux. Arch Otolaryngol Head Neck Surg 2005;131:315-20, doi:10.1001/archotol.131.4.315. (Pubitemid 40520523)
14. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the Reflux Finding Score. Laryngoscope 2001;111:1313-7, doi:10.1097/00005537- 200108000-00001. (Pubitemid 32730172)
15. Kamel PL, Hanson D, Kahrilas PL. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994;96:321-6, doi:10.1016/0002-9343(94)90061-2. (Pubitemid 24127267)
16. Hammer HF. Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist's point of view. Dig Dis 2009;27:7-14, doi:10.1159/000210098.
17. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32-5, doi:10.1067/mhn.2002.125760. (Pubitemid 41115024)
18. Ergun GA, Kahrilas PJ. Clinical applications of esophageal manometry and pH monitoring. Am J Gastroenterol 1996;91:1077-89. (Pubitemid 26175463)
19. Achem SR, Robinson M. A prokinetic approach to treatment of gastroesophageal reflux disease. Dig Dis 1998;16:38-46, doi:10.1159/000016847. (Pubitemid 128527700)
20. Iwanaga Y, Miyashita N, Morikawa K, et al. A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine. Gastroenterology 1990;99:401-8. (Pubitemid 20219096)